Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard H Drew

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Pharmacotherapy|May 24, 2014
Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactamLindsey D Burgess, Richard H Drew
Pharmacy Practice|October 9, 2019
Impact of select risk factors on treatment outcome in adults with candidemiaBrandon Hill, Richard H Drew, Dustin Wilson
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 6, 2006
Information technology for optimizing the management of infectious diseasesRichard H Drew, Kensaku Kawamoto, Martha B Adams
Infection and Drug Resistance|June 23, 2011
Potential role of tigecycline in the treatment of community-acquired bacterial pneumoniaMary L Townsend, Melanie W Pound, Richard H Drew
Expert Review of Anti-Infective Therapy|August 9, 2011
Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapyV Paul DiMondi, Richard H Drew, Luke F Chen
Expert Opinion on Emerging Drugs|April 26, 2006
Emerging echinocandins for treatment of invasive fungal infectionsMichelle S Turner, Richard H Drew, John R Perfect
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2005
Is it time to abandon the use of amphotericin B bladder irrigation?Richard H Drew, Rebekah R Arthur, John R Perfect
Mycopathologia|March 25, 2009
Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an updateDustin T Wilson, Richard H Drew, John R Perfect
Current Opinion in Infectious Diseases|April 20, 2002
Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumoniaMelanie W Pound, Richard H Drew, John R Perfect
Therapeutics and Clinical Risk Management|June 3, 2008
Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infectionsMary L Townsend, Melanie W Pound, Richard H Drew
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Pharmacotherapy|May 24, 2014
Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactamLindsey D Burgess, Richard H Drew
Pharmacy Practice|October 9, 2019
Impact of select risk factors on treatment outcome in adults with candidemiaBrandon Hill, Richard H Drew, Dustin Wilson
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 6, 2006
Information technology for optimizing the management of infectious diseasesRichard H Drew, Kensaku Kawamoto, Martha B Adams
Infection and Drug Resistance|June 23, 2011
Potential role of tigecycline in the treatment of community-acquired bacterial pneumoniaMary L Townsend, Melanie W Pound, Richard H Drew
Expert Review of Anti-Infective Therapy|August 9, 2011
Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapyV Paul DiMondi, Richard H Drew, Luke F Chen
Expert Opinion on Emerging Drugs|April 26, 2006
Emerging echinocandins for treatment of invasive fungal infectionsMichelle S Turner, Richard H Drew, John R Perfect
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2005
Is it time to abandon the use of amphotericin B bladder irrigation?Richard H Drew, Rebekah R Arthur, John R Perfect
Mycopathologia|March 25, 2009
Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an updateDustin T Wilson, Richard H Drew, John R Perfect
Current Opinion in Infectious Diseases|April 20, 2002
Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumoniaMelanie W Pound, Richard H Drew, John R Perfect
Therapeutics and Clinical Risk Management|June 3, 2008
Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infectionsMary L Townsend, Melanie W Pound, Richard H Drew
Pageof 5